Vec­tor Labs de­cou­ples from Mar­a­vai, pop­ping up shop with pri­vate cap­i­tal, new CEO on board

Vec­tor Lab­o­ra­to­ries has been in busi­ness since the 1970s, de­vel­op­ing and man­u­fac­tur­ing pro­tein de­tec­tion to help study tis­sues and cells. Af­ter Tues­day, the team will do so as a stand-alone com­pa­ny flush with pri­vate cap­i­tal and head­ed by a new CEO.

Vec­tor an­nounced a $124 mil­lion cash buy­out backed by pri­vate eq­ui­ty firm Thomp­son Street Cap­i­tal Part­ners on Tues­day to fund its ex­pan­sion in pro­tein de­tec­tion. The mon­ey will help Vec­tor with fu­ture merg­ers and ac­qui­si­tions, and help com­mer­cial­ize its la­bel­ing and de­tec­tion tech­nol­o­gy in its pipeline.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN